Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Bioprinting "Track B"

Luiz Bertassoni's Biography

Luiz Bertassoni, Associate Professor, Biomaterials and Biomechanics, School of Dentistry, Cancer Early Detection Advanced Research, Knight Cancer Institute, Oregon Health & Sciences University

Dr. Luiz Bertassoni obtained a PhD in Biomaterials from University of Sydney, and two postdoctoral degrees in Bioengineering from University of California San Francisco, and the Division of Health Sciences and Technology at Harvard Medical School and MIT. Currently, Dr. Bertassoni is an Associate Professor at Oregon Health and Science University (OHSU). He holds appointments at the Department of Restorative Dentistry, the OHSU Center for Regenerative Medicine, the Department of Biomedical Engineering and the Cancer Early Detection Advanced Research center (CEDAR) at the Knight Cancer Institute. Dr. Bertassoni’s encompasses various aspects of micro-scale technologies and bioprinting for tissue regeneration; nanoscale structural and mechanical properties of mineralized tissues; and different aspects in the field of ‘organs-on-a-chip’. His research has appeared in journals such as Nature Communications, Advanced Materials, Biofabrication, Lab on a Chip and others. Luiz has published over 45 manuscripts, including research articles, reviews and book chapters, and is a recipient of 28 national and international awards. He also serves as a reviewer for over 50 international peer-reviewed journals and an editorial board member of 5 journals.

Luiz Bertassoni Image

Luncheon Presentation: 3D Stereolitography Bioprinting of Cell-Laden Hydrogel Microarrays and LEGO-like Modular Bioceramics for Tissue Engineering

Thursday, 4 October 2018 at 12:45

Add to Calendar ▼2018-10-04 12:45:002018-10-04 13:45:00Europe/LondonLuncheon Presentation: 3D Stereolitography Bioprinting of Cell-Laden Hydrogel Microarrays and LEGO-like Modular Bioceramics for Tissue

Fabrication of three-dimensional tissues with controlled microarchitectures has been shown to enhance tissue functionality. 3D printing can be used to precisely position cells and cell-laden materials to generate controlled tissue architectures. Therefore, it represents an exciting alternative for organ fabrication. Our group has been interested in developing innovative printing-based technologies to improve our ability to regenerate tissues with improved function, as well as to engineer hydrogel based microfluidic devices. In this seminar, we will present SLA/DLP-based 3D printing methods to fabricate high-throughput screening platforms to probe mechanotransduction and geometry-controlled mechanisms of stem cell differentiation. Further, we will discuss recent methods our lab has developed to engineer hard tissues using stereolitography printing of high-density bioceramics that can be stacked with multiple 3D geometries and improved regenerative capacity.

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/London3D-Bioprinting "Track B"